Company finalizing preparations for end of January 2026 U.S. FDA Biologics License Application (BLA) submission for OST-HER2 ...

Stage 4 RCC is metastatic, with common spread to lungs, bones, liver, brain, and adrenal glands. Understanding IMDC risk is crucial for treatment planning. Systemic therapies, including combination ...

Researchers are targeting dormant tumour cells that might explain why some cancers reappear long after successful treatment.

Researchers at USF Health have discovered a new way opioid receptors can work that may lead to safer pain medications. Their ...

The US government is approving the drug leucovorin to address rising rates of autism, despite limited evidence that it works.

Wegovy Weight-Loss Pills Are Now Available in the U.S.—Here’s What That Means The first GLP-1 pills for weight loss are ...

Maia Kinney-Petrucha speaks with Business Insider about being diagnosed with obsessive-compulsive disorder at age 4.

Rilzabrutinib (Wayrilz; Sanofi), a BTK inhibitor, targets immune-mediated platelet destruction in immune thrombocytopenia (ITP) and has demonstrated a favorable safety profile.

A protein once thought to simply help cancer cells avoid death turns out to do much more. MCL1 actively drives cancer ...

A team of cancer biologists led by Princeton’s Yibin Kang has resolved a confounding paradox about retinoids and cancer cells ...